ASCO GU 2021: Nivolumab plus cabozantinib combination for the first-line treatment of advanced kidney cancer
The past couple of years has seen a number of [...]
The past couple of years has seen a number of [...]
The Food and Drug Administration (FDA) in the United States has [...]
Four-year follow up data are now available from the CheckMate [...]
A recent phase 1 trial showed that treatment with nivolumab [...]
A protein called γ-glutamyltransferase can predict survival in patients with [...]
In this phase 1b/2 study the researchers looked at a [...]
Tivozanib is a drug that blocks the blood supply to [...]
This recent retrospective study included 84 patients with metastatic renal [...]
Nivolumab alone and in combination with ipilimumab is used for the treatment of [...]
Further results from the ongoing CheckMate 214 phase III study [...]